CASI Pharmaceuticals (CASIF) Tax Provisions (2023)
CASI Pharmaceuticals (CASIF) reported Tax Provisions of $80000.0 for Q2 2023.
CASI Pharmaceuticals (CASIF) Tax Provisions (2023) Analysis & Trends
CASI Pharmaceuticals has reported Tax Provisions for 1 years, with the latest figure at $80000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | - |
| 10 | CASI Pharmaceuticals | - | - | 3.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 80,000.00 |